Comparable Disease Severity by Influenza Virus Subtype in the Acute Respiratory Infection Consortium Natural History Study.


Journal

Military medicine
ISSN: 1930-613X
Titre abrégé: Mil Med
Pays: England
ID NLM: 2984771R

Informations de publication

Date de publication:
14 08 2020
Historique:
received: 19 09 2019
revised: 13 12 2019
accepted: 07 01 2020
pubmed: 27 6 2020
medline: 13 4 2021
entrez: 27 6 2020
Statut: ppublish

Résumé

Since the influenza A/H1N1 pandemic of 2009 to 2010, numerous studies have described the clinical course and outcome of the different subtypes of influenza (A/H1N1, A/H3N2, and B). A recent systematic literature review concluded that there were no appreciable differences in either clinical presentation or disease severity among these subtypes, but study parameters limit the applicability of these results to military populations. We sought to evaluate differences in disease severity among influenza subtypes in a cohort of healthy, primarily outpatient adult U.S. Department of Defense beneficiaries. From 2009 to 2014, we enrolled otherwise healthy adults age 18 to 65 years with influenza-like illness in an observational cohort study based in 5 U.S. military medical centers. Serial nasopharyngeal swabs were collected for determination of etiology and viral shedding by polymerase chain reaction. The presence and severity of symptoms was assessed by interview and patient diary. Over a 5-year period, a total of 157 adults with laboratory-confirmed influenza and influenza subtype were enrolled. Of these, 69 (44%) were positive for influenza A(H1N1), 69 (44%) for influenza A(H3N2), and 19 (12%) for influenza B. About 61% were male, 64% were active duty military personnel, and 72% had received influenza vaccine in the past 8 months. Almost 10% were hospitalized with influenza. Seasonal influenza virus distribution among enrollees mirrored that of nationwide trends each year of study. Individuals with A/H1N1 had upper respiratory composite scores that were lower than those with A/H3N2. Multivariate models indicated that individuals with A(H1N1) and B had increased lower respiratory symptom scores when compared to influenza A(H3N2) (A[H1N1]: 1.51 [95% CI 0.47, 2.55]; B: 1.46 [95% CI 0.09, 2.83]), whereas no other differences in symptom severity scores among influenza A(H1N1), influenza A(H3N2), and influenza B infection were observed. Overall, influenza season (maximum in 2012-2013 season) and female sex of the participant were found to be associated with increased influenza symptom severity. Our study of influenza in a cohort of otherwise healthy, outpatient adult Department of Defense beneficiaries over 5 influenza seasons revealed few differences between influenza A(H1N1), influenza A(H3N2), and influenza B infection with respect to self-reported disease severity or clinical outcomes. This study highlights the importance of routine, active, and laboratory-based surveillance to monitor ongoing trends and severity of influenza in various populations to inform prevention measures.

Identifiants

pubmed: 32588899
pii: 5862944
doi: 10.1093/milmed/usaa120
pmc: PMC7427663
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1008-e1015

Subventions

Organisme : NIAID NIH HHS
ID : Y01 AI005072
Pays : United States

Informations de copyright

© Association of Military Surgeons of the United States 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Postgrad Med J. 2010 Sep;86(1019):515-21
pubmed: 20693151
MMWR Morb Mortal Wkly Rep. 2010 Oct 8;59(39):1270-3
pubmed: 20930705
Infect Control Hosp Epidemiol. 2010 Jul;31(7):676-82
pubmed: 20500086
BMC Infect Dis. 2012 Jan 20;12:12
pubmed: 22264216
MMWR Morb Mortal Wkly Rep. 2014 Dec 19;63(50):1189-94
pubmed: 25522086
J Virol Methods. 2011 Apr;173(1):60-6
pubmed: 21256867
PLoS One. 2012;7(1):e30279
pubmed: 22291929
PLoS One. 2018 Mar 22;13(3):e0194180
pubmed: 29566007
Mil Med. 2019 Nov 1;184(Suppl 2):44-50
pubmed: 31778194
Arch Intern Med. 2010 May 24;170(10):861-7
pubmed: 20498413
Influenza Other Respir Viruses. 2018 Nov;12(6):780-792
pubmed: 29858537
JAMA. 2010 Sep 8;304(10):1091-8
pubmed: 20823435
MMWR Morb Mortal Wkly Rep. 2009 Apr 24;58(15):400-2
pubmed: 19390508
J Clin Microbiol. 2011 Jul;49(7):2614-9
pubmed: 21593260
Clin Microbiol Infect. 2012 Mar;18(3):E55-62
pubmed: 22264321
Ann Lab Med. 2017 May;37(3):267-271
pubmed: 28224774
MMWR Morb Mortal Wkly Rep. 2012 Jun 8;61(22):414-20
pubmed: 22672977
N Engl J Med. 2010 Jun 10;362(23):2175-2184
pubmed: 20558368
MMWR Morb Mortal Wkly Rep. 2013 Jun 14;62(23):473-9
pubmed: 23760189
MMWR Morb Mortal Wkly Rep. 2011 Feb 18;60(6):175-81
pubmed: 21330967
MMWR Morb Mortal Wkly Rep. 2014 Jun 6;63(22):483-90
pubmed: 24898165
MMWR Morb Mortal Wkly Rep. 2013 Dec 20;62(50):1032-6
pubmed: 24352068
J Clin Virol. 2015 Mar;64:74-82
pubmed: 25728083
MMWR Morb Mortal Wkly Rep. 2012 Dec 7;61(48):990-3
pubmed: 23222374
PLoS One. 2019 Mar 28;14(3):e0214517
pubmed: 30921408
Clin Respir J. 2014 Apr;8(2):185-91
pubmed: 24106842
Vaccine. 2015 Dec 16;33(51):7160-7167
pubmed: 26562321
Emerg Infect Dis. 2010 Sep;16(9):1388-95
pubmed: 20735922
J Clin Virol. 2012 Jun;54(2):135-40
pubmed: 22398034
MMWR Morb Mortal Wkly Rep. 2011 Jun 3;60(21):705-12
pubmed: 21637185
Emerg Infect Dis. 2013 May;19(5):748-55
pubmed: 23697801
Wkly Epidemiol Rec. 2009 Jun 19;84(25):249-57
pubmed: 19537358
J Infect Dis. 2016 May 15;213(10):1546-56
pubmed: 26743842
J Hosp Infect. 2017 Aug;96(4):366-370
pubmed: 28571763
Mil Med. 2017 Sep;182(9):e1917-e1921
pubmed: 28885955

Auteurs

Christina Schofield (C)

Infectious Disease Service, Madigan Army Medical Center, 9040 Jackson Ave, Fort Lewis, Washington, Washington DC 98431.

Rhonda E Colombo (RE)

Infectious Disease Service, Madigan Army Medical Center, 9040 Jackson Ave, Fort Lewis, Washington, Washington DC 98431.
Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD 2088.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 2088.

Stephanie A Richard (SA)

Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD 2088.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 2088.

Wei-Ju Chen (WJ)

Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD 2088.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 2088.

Mary P Fairchok (MP)

Infectious Disease Service, Madigan Army Medical Center, 9040 Jackson Ave, Fort Lewis, Washington, Washington DC 98431.
Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD 2088.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 2088.

Ryan C Maves (RC)

Division of Infectious Disease, Naval Medical Center San Diego, 34800 Bob Wilson Dr, San Diego, CA 92134.

John C Arnold (JC)

Division of Infectious Disease, Naval Medical Center San Diego, 34800 Bob Wilson Dr, San Diego, CA 92134.

Patrick J Danaher (PJ)

Infectious Disease Service, San Antonio Military Medical Center, 3551 Roger Brooke Dr, San Antonio, TX 78234.

Robert G Deiss (RG)

Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD 2088.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 2088.
Division of Infectious Disease, Naval Medical Center San Diego, 34800 Bob Wilson Dr, San Diego, CA 92134.

Tahaniyat Lalani (T)

Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD 2088.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 2088.
Infectious Disease Division, Naval Medical Center Portsmouth, 620 John Paul Jones Cir, Portsmouth, VA 23708.

Michael Rajnik (M)

Division of Infectious Disease, Walter Reed National Military Medical Center, 4494 Palm Rd N, Bethesda, MD 20889.

Eugene V Millar (EV)

Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD 2088.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 2088.

Christian L Coles (CL)

Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD 2088.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 2088.

Timothy H Burgess (TH)

Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD 2088.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH